The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albumin (as Excipient) Market Research Report 2024
Synopsis
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Albumin (as Excipient) market was valued at US$ 4340.4 million in 2023 and is anticipated to reach US$ 6601.7 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
Report Scope
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (as Excipient) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Albumin (as Excipient) market was valued at US$ 4340.4 million in 2023 and is anticipated to reach US$ 6601.7 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
Report Scope
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (as Excipient) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albumin (as Excipient) Market Overview
1.1 Product Overview and Scope of Albumin (as Excipient)
1.2 Albumin (as Excipient) Segment by Type
1.2.1 Global Albumin (as Excipient) Market Value Comparison by Type (2024-2030)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) Segment by Application
1.3.1 Global Albumin (as Excipient) Market Value by Application: (2024-2030)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Global Albumin (as Excipient) Market Size Estimates and Forecasts
1.4.1 Global Albumin (as Excipient) Revenue 2019-2030
1.4.2 Global Albumin (as Excipient) Sales 2019-2030
1.4.3 Global Albumin (as Excipient) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Albumin (as Excipient) Market Competition by Manufacturers
2.1 Global Albumin (as Excipient) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Albumin (as Excipient) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Albumin (as Excipient) Average Price by Manufacturers (2019-2024)
2.4 Global Albumin (as Excipient) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
2.7 Albumin (as Excipient) Market Competitive Situation and Trends
2.7.1 Albumin (as Excipient) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Albumin (as Excipient) Players Market Share by Revenue
2.7.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albumin (as Excipient) Retrospective Market Scenario by Region
3.1 Global Albumin (as Excipient) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Albumin (as Excipient) Global Albumin (as Excipient) Sales by Region: 2019-2030
3.2.1 Global Albumin (as Excipient) Sales by Region: 2019-2024
3.2.2 Global Albumin (as Excipient) Sales by Region: 2025-2030
3.3 Global Albumin (as Excipient) Global Albumin (as Excipient) Revenue by Region: 2019-2030
3.3.1 Global Albumin (as Excipient) Revenue by Region: 2019-2024
3.3.2 Global Albumin (as Excipient) Revenue by Region: 2025-2030
3.4 North America Albumin (as Excipient) Market Facts & Figures by Country
3.4.1 North America Albumin (as Excipient) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Albumin (as Excipient) Sales by Country (2019-2030)
3.4.3 North America Albumin (as Excipient) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albumin (as Excipient) Market Facts & Figures by Country
3.5.1 Europe Albumin (as Excipient) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Albumin (as Excipient) Sales by Country (2019-2030)
3.5.3 Europe Albumin (as Excipient) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albumin (as Excipient) Market Facts & Figures by Country
3.6.1 Asia Pacific Albumin (as Excipient) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Albumin (as Excipient) Sales by Country (2019-2030)
3.6.3 Asia Pacific Albumin (as Excipient) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Albumin (as Excipient) Market Facts & Figures by Country
3.7.1 Latin America Albumin (as Excipient) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Albumin (as Excipient) Sales by Country (2019-2030)
3.7.3 Latin America Albumin (as Excipient) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country
3.8.1 Middle East and Africa Albumin (as Excipient) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Albumin (as Excipient) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Albumin (as Excipient) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albumin (as Excipient) Sales by Type (2019-2030)
4.1.1 Global Albumin (as Excipient) Sales by Type (2019-2024)
4.1.2 Global Albumin (as Excipient) Sales by Type (2025-2030)
4.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2019-2030)
4.2 Global Albumin (as Excipient) Revenue by Type (2019-2030)
4.2.1 Global Albumin (as Excipient) Revenue by Type (2019-2024)
4.2.2 Global Albumin (as Excipient) Revenue by Type (2025-2030)
4.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2019-2030)
4.3 Global Albumin (as Excipient) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Albumin (as Excipient) Sales by Application (2019-2030)
5.1.1 Global Albumin (as Excipient) Sales by Application (2019-2024)
5.1.2 Global Albumin (as Excipient) Sales by Application (2025-2030)
5.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2019-2030)
5.2 Global Albumin (as Excipient) Revenue by Application (2019-2030)
5.2.1 Global Albumin (as Excipient) Revenue by Application (2019-2024)
5.2.2 Global Albumin (as Excipient) Revenue by Application (2025-2030)
5.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2019-2030)
5.3 Global Albumin (as Excipient) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Albumin (as Excipient) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Albumin (as Excipient) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Albumin (as Excipient) Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Albumin (as Excipient) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Bio
6.5.1 Hualan Bio Corporation Information
6.5.2 Hualan Bio Description and Business Overview
6.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
6.5.5 Hualan Bio Recent Developments/Updates
6.6 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CBPO Albumin (as Excipient) Product Portfolio
6.6.5 CBPO Recent Developments/Updates
6.7 Shanghai RAAS
6.6.1 Shanghai RAAS Corporation Information
6.6.2 Shanghai RAAS Description and Business Overview
6.6.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
6.7.5 Shanghai RAAS Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Corporation Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kedrion Albumin (as Excipient) Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Corporation Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 LFB Group Albumin (as Excipient) Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Albumedix
6.10.1 Albumedix Corporation Information
6.10.2 Albumedix Description and Business Overview
6.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Albumedix Albumin (as Excipient) Product Portfolio
6.10.5 Albumedix Recent Developments/Updates
6.11 Biotest
6.11.1 Biotest Corporation Information
6.11.2 Biotest Albumin (as Excipient) Description and Business Overview
6.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biotest Albumin (as Excipient) Product Portfolio
6.11.5 Biotest Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Albumin (as Excipient) Description and Business Overview
6.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Merck Albumin (as Excipient) Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Ventria (InVitria)
6.13.1 Ventria (InVitria) Corporation Information
6.13.2 Ventria (InVitria) Albumin (as Excipient) Description and Business Overview
6.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
6.13.5 Ventria (InVitria) Recent Developments/Updates
6.14 HiMedia
6.14.1 HiMedia Corporation Information
6.14.2 HiMedia Albumin (as Excipient) Description and Business Overview
6.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HiMedia Albumin (as Excipient) Product Portfolio
6.14.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albumin (as Excipient) Industry Chain Analysis
7.2 Albumin (as Excipient) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albumin (as Excipient) Production Mode & Process
7.4 Albumin (as Excipient) Sales and Marketing
7.4.1 Albumin (as Excipient) Sales Channels
7.4.2 Albumin (as Excipient) Distributors
7.5 Albumin (as Excipient) Customers
8 Albumin (as Excipient) Market Dynamics
8.1 Albumin (as Excipient) Industry Trends
8.2 Albumin (as Excipient) Market Drivers
8.3 Albumin (as Excipient) Market Challenges
8.4 Albumin (as Excipient) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
